Imatinib mesylate
Imatinib mesylate | |
---|---|
Term | Imatinib mesylate |
Short definition | imatinib mesylate (ih-MA-tih-nib MEH-zih-layt) A drug used to treat certain types of leukemia and other blood cancers, gastrointestinal stromal tumors, skin tumors called dermatofibrosarcoma protuberans, and a rare condition called systemic mastocytosis. It is also being studied in the treatment of other diseases and cancers. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
imatinib mesylate - (pronounced) (ih-MA-tih-nib MEH-zih-layt) A drug used to treat certain types of leukemia and other blood cancers, gastrointestinal stromal tumors, skin tumors called dermatofibrosarcoma protuberans, and a rare condition called systemic mastocytosis. It is also being studied in the treatment of other diseases and cancers. Imatinib mesylate blocks certain proteins made by the BCR-ABL, PDGFR, or c-KITO oncogene, which can help prevent cancer cells from growing and kill them. Imatinib mesylate is a type of tyrosine kinase inhibitor. Also called Gleevec and STI571
External links
- Medical encyclopedia article on Imatinib mesylate
- Wikipedia's article - Imatinib mesylate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski